Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Erik P Sulman, MD,PhD
Duke University
Principal Investigator - Sylvia C Kurz, MD, PhD
Yale University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, Irvine
Irvine, California, United States
- University of California San Diego - Moores Cancer Center
La Jolla, California, United States
- Yale University
New Haven, Connecticut, United States
- Baptist Md Anderson Cancer Center
Jacksonville, Florida, United States
- Baptist Health Medical Group Oncology
Miami, Florida, United States
- University of Miami
Miami, Florida, United States
- Piedmont Healthcare
Atlanta, Georgia, United States
- Indiana University
Indianapolis, Indiana, United States
- Dana-Farber/harvard Cancer Center
Boston, Massachusetts, United States
- University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, United States
- Nyu Lagone Health
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Dec 2025
- Primary completion
- 31 Aug 2029
- Completion
- 31 Aug 2030
- Last update posted
- 20 Aug 2026
- Registered enrollment
- 130
- Registry id
- NCT06955169
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.